<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GuosenHealthcare | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-30T16:14:38+08:00</updated>
  <subtitle>国信医药最新研究成果、行业深度资讯展示与交流平台，引领健康投资、健康生活新风尚！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【国信医药】药明康德：Q3增长提速，龙头强者恒强（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/dLox-LUFQW5gJLWKI0Eb9w</id>
    <link href="https://mp.weixin.qq.com/s/dLox-LUFQW5gJLWKI0Eb9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】迈瑞医疗：器械龙头加速全球化，抗疫产品延续高增长（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/Az5olI-RYr7Chs6KrGxFLw</id>
    <link href="https://mp.weixin.qq.com/s/Az5olI-RYr7Chs6KrGxFLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】乐普医疗：扣非业绩稳健增长，期待创新器械放量（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/6HYdeBv-5qyDOLG1eexU_A</id>
    <link href="https://mp.weixin.qq.com/s/6HYdeBv-5qyDOLG1eexU_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】泰格医药：业绩符合预期，Q4有望持续恢复（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/9AD3787yvMIRzmQceNNgpQ</id>
    <link href="https://mp.weixin.qq.com/s/9AD3787yvMIRzmQceNNgpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】通化东宝：单季增速略超预期，甘精持续放量（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/2DulLBRLYkfMV6cXFycr1Q</id>
    <link href="https://mp.weixin.qq.com/s/2DulLBRLYkfMV6cXFycr1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】白云山：Q3 强势回暖，子公司分拆上市推进（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/WaGls0_YXxDhRrUmXl8xRQ</id>
    <link href="https://mp.weixin.qq.com/s/WaGls0_YXxDhRrUmXl8xRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】天坛生物：Q3增速回升，定增募投新产能（三季报点评）</title>
    <updated>2020-10-29T10:00:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/GJ4NZ6-cWu2F7kw1rgd3MQ</id>
    <link href="https://mp.weixin.qq.com/s/GJ4NZ6-cWu2F7kw1rgd3MQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】华大基因：新冠检测持续，海外扩张加速（三季报点评）</title>
    <updated>2020-10-29T10:00:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/t2tdOQoyyD5fDGDhN-C8rw</id>
    <link href="https://mp.weixin.qq.com/s/t2tdOQoyyD5fDGDhN-C8rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】凯利泰：单季恢复正增长，中长期持续看好（三季报点评）</title>
    <updated>2020-10-29T10:00:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/2nKLxzH7ZK8G39lzipctLw</id>
    <link href="https://mp.weixin.qq.com/s/2nKLxzH7ZK8G39lzipctLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】迪安诊断：业绩超预期，实验室扭亏加速（三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/t0WXSrVpmmkoHBtBMSvUBA</id>
    <link href="https://mp.weixin.qq.com/s/t0WXSrVpmmkoHBtBMSvUBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】爱尔眼科：业绩超预期，眼科真龙头（三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/eh5yoV_hcnhKLhQs26KOLQ</id>
    <link href="https://mp.weixin.qq.com/s/eh5yoV_hcnhKLhQs26KOLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】贝达药业：埃克替尼稳健增长，业绩符合预期 （三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/_SRRIipjYSU66ixHD1PksA</id>
    <link href="https://mp.weixin.qq.com/s/_SRRIipjYSU66ixHD1PksA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】长春高新：金赛稳健增长，疫苗快速放量（三季报点评）</title>
    <updated>2020-10-27T14:42:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/f4tZ5F3nVilkXL23dx09Ng</id>
    <link href="https://mp.weixin.qq.com/s/f4tZ5F3nVilkXL23dx09Ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】凯莱英：业绩符合预期，维持高速增长（三季报点评）</title>
    <updated>2020-10-26T13:52:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/V9j7YwHXi4IIweVElJf49A</id>
    <link href="https://mp.weixin.qq.com/s/V9j7YwHXi4IIweVElJf49A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】丽珠集团：收入高速增长，业绩符合预期（三季报点评）</title>
    <updated>2020-10-26T13:52:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/hTEGfHbPKlsMISyt5j_03g</id>
    <link href="https://mp.weixin.qq.com/s/hTEGfHbPKlsMISyt5j_03g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】白马边际变化敏感，重磅药政变化临近（周观点）</title>
    <updated>2020-10-25T23:32:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/k81prL0tjFgqACXSXA32bg</id>
    <link href="https://mp.weixin.qq.com/s/k81prL0tjFgqACXSXA32bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】国药股份：疫情影响逐渐消退，精麻龙头现金流向好（三季报点评）</title>
    <updated>2020-10-25T23:32:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/iyeioZSKJhN0Xwrc-Jj0WA</id>
    <link href="https://mp.weixin.qq.com/s/iyeioZSKJhN0Xwrc-Jj0WA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】佰仁医疗：疫情后快速恢复，瓣膜增长强劲（三季报点评）</title>
    <updated>2020-10-23T15:53:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/d1mimz03jtoTsQiYciWGAA</id>
    <link href="https://mp.weixin.qq.com/s/d1mimz03jtoTsQiYciWGAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】DRGs试点进一步扩大，把握三条投资主线（行业重大事件快评）</title>
    <updated>2020-10-21T17:11:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/YCAtHANjUBGvG5u_OFK4GQ</id>
    <link href="https://mp.weixin.qq.com/s/YCAtHANjUBGvG5u_OFK4GQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】冠脉支架集采文件出台，不确定性即将出清（行业重大事件快评）</title>
    <updated>2020-10-19T19:00:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/p5CQqX_57f9H0u9FthBrRQ</id>
    <link href="https://mp.weixin.qq.com/s/p5CQqX_57f9H0u9FthBrRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>